| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 148.94M | 125.06M | 163.30M | 126.50M | 85.00M | 66.28M |
| Gross Profit | 41.41M | 39.33M | 46.44M | 39.67M | 27.53M | 19.92M |
| EBITDA | 9.30M | 6.76M | 18.58M | 13.57M | 6.54M | 6.37M |
| Net Income | 2.42M | 512.00K | 8.87M | 6.69M | 2.52M | 3.95M |
Balance Sheet | ||||||
| Total Assets | 108.76M | 104.34M | 113.58M | 113.79M | 62.33M | 53.97M |
| Cash, Cash Equivalents and Short-Term Investments | 5.77M | 3.51M | 8.45M | 12.22M | 4.98M | 6.91M |
| Total Debt | 17.83M | 16.57M | 16.69M | 16.70M | 5.64M | 6.29M |
| Total Liabilities | 46.52M | 42.85M | 48.96M | 55.83M | 35.25M | 28.46M |
| Stockholders Equity | 62.24M | 61.50M | 64.62M | 57.91M | 27.08M | 25.50M |
Cash Flow | ||||||
| Free Cash Flow | 1.75M | 4.35M | 8.12M | 6.71M | 3.27M | 5.84M |
| Operating Cash Flow | 3.99M | 7.84M | 10.95M | 9.05M | 5.04M | 6.50M |
| Investing Cash Flow | -5.35M | -5.38M | -8.21M | -35.48M | -4.27M | -4.70M |
| Financing Cash Flow | -2.92M | -7.37M | -6.49M | 35.74M | -4.78M | 1.64M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Neutral | £67.97M | 12.03 | 9.07% | ― | 7.36% | 31.93% | |
68 Neutral | £78.57M | 8.13 | 3.91% | 1.56% | 8.75% | -54.73% | |
68 Neutral | £81.60M | 20.27 | 16.76% | ― | -3.41% | 58.10% | |
67 Neutral | £208.56M | 25.56 | 3.10% | 2.19% | 10.66% | 21.19% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
54 Neutral | £213.67M | -4.02 | -31.21% | ― | -16.33% | -448.12% | |
54 Neutral | £90.91M | -24.70 | -5.90% | ― | -7.35% | -222.10% |